Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Cardiotoxicity 5Neoplasms 3Breast Neoplasms 3Heart Failure 2Dyslipidemias 2Cardiovascular Diseases 2Ventricular Dysfunction, Left 1Thoracic Neoplasms 1Smoking 1Pulmonary Disease, Chronic Obstructive 1Overweight 1Obesity 1Noncommunicable Diseases 1Metabolic Syndrome 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypokinesia 1Hypertension 1Hyperglycemia 1Diabetes Mellitus 1Coronary Disease 1Cerebrovascular Disorders 1Central Nervous System Neoplasms 1Cardiomyopathies 1Atrial Fibrillation 1Asthma 1Alcohol Drinking 1

Interventions

Magnetoencephalography 1Electrocardiography 1Eating 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cerebrovascular Disorders × Electrocardiography × Clear all
NCT06812767 2025-02-06

FORTUNE

National Medical Research Center for Therapy and Preventive Medicine

Enrolling by invitation
2,000 enrolled
Other

Noncommunicable Diseases, Alcohol Drinking, Asthma, Cerebrovascular Disorders, Coronary Disease, Diabetes Mellitus, Hyperglycemia, Hypertension, Neoplasms, Obesity, Smoking, Hypokinesia, Pulmonary Disease, Chronic Obstructive, Dyslipidemias, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡